|
|
|
For Immediate Release
Yvonne
M. Psaila
Director
of Marketing & Communications
Keystone
Symposia on Molecular & Cellular Biology
+
1 970-262-2676
or
Eileen
Curran
Senior Director, Communications & Public Relations
National Multiple Sclerosis Society
+1 617-719-3202
Keystone Symposia Hosting Free Online
Event on Multiple Sclerosis
SILVERTHORNE,
CO August 1, 2017 Keystone Symposia is pleased to announce that on August
15, 2017, it will broadcast an online panel discussion on "Multiple Sclerosis: Conventional and Alternative Therapeutic
Approaches" at 11:30 AM Eastern Time. Organized in collaboration with and
sponsored by the National Multiple Sclerosis Society, this free event will
feature approximately 60 minutes of panelist discussion followed by live
audience Q&A with some of the panelists.
The
event will be moderated by Dr. Bruce Bebo, Executive Vice President of Research
for the National Multiple Sclerosis Society, and Dr. Patrizia Casaccia, Director
of Neuroscience at the Advanced Science Research Center at CUNY. Joining them
on the panel are Dr. Dennis Bourdette of Oregon Health & Science
University, Dr. Ari Green of the University of California, San Francisco and
Dr. Andrew Goodman of the University of Rochester Medical Center. Dr. Douglas
Landsman, Associate Vice President of Biomedical Research at the National
Multiple Sclerosis Society, will also join for the online Q&A.
It
is estimated that 2.3 million individuals worldwide suffer from multiple
sclerosis (MS), a neurodegenerative disease that occurs when the immune system attacks a fatty material called myelin that protects nerve
cells. MS exhibits an extremely wide spectrum of clinical manifestations. While many
strides have been made in treatment, particularly in the area of
immunomodulatory and anti-inflammatory therapy, and some patients remain in a
relapsing-remitting cycle, others suffer a more progressive form of the disease.
There is an urgent need for new therapeutics for these patients, and there are
exciting therapies on the horizon relating to stem cells/bone marrow transplants,
immunoblation and drug therapies, as well as wellness approaches relating to
diet.
According
to Dr. Bruce Bebo, "We are thrilled to be partnering with Keystone Symposia on
this online panel discussion. MS research is rapidly evolving, and this novel format
allows for the timely communication of the latest research advances." Adds Dr.
Patrizia Casaccia, "While current treatments have been remarkably effective in
controlling relapses, there is increasing interest in therapies aimed at
repairing damaged cells and restoring lost function. The goal of this webinar
is to provide a forum for discussion on therapeutic approaches which bear the
promise to meet these current unmet needs."
More
information about this event can be found at http://bit.ly/vksMS.
While the event is free, advance registration is required. Viewers can submit
questions for the panel either during online registration or via the chat room
during the event itself.
About Virtual Keystone
Symposia
Keystone
Symposia has in the past held four-day conferences on multiple sclerosis, and
MS is a component of many of its regular immunology and neurobiology
conferences, including its Neuroinflammation conference, to be held next in
June 2018. The new "Virtual Keystone Symposia" format is a way to hold forums
on timely topics that can benefit from an accelerated production schedule. The
format also serves as a way to share the scientific insights gained with a more
extensive global audience. To date since this new programming model was
launched a little over three years ago, more than 6,000 people have participated
in Virtual Keystone Symposia events, which have been held on diverse topics
including neuroscience, genome editing, noncoding RNAs, malaria, HIV antibodies
and health disparities. All past events are available to view in archived form
at http://virtual.keystonesymposia.org.
About
Keystone Symposia on Molecular and Cellular Biology
Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3)
nonprofit organization, has been conducting internationally renowned, open
scientific conferences since its founding as UCLA Symposia in 1972 and has been
headquartered in Summit County, Colorado, USA since 1990. It will convene 60 face-to-face
conferences in the 2017-2018 season, the majority of which will take place
between January and April 2018, on topics ranging from cancer and immunology to
neuroscience and genomics. Registration fees are supplemented by generous financial
support from corporate, foundation and individual donors as well as government
grants. More information about the organization and its meetings is located at http://ww.keystonesymposia.org and http://ww.keystonesymposia.org/meetings,
respectively.
About the National Multiple Sclerosis Society
The Society mobilizes people and resources so that everyone affected by
multiple sclerosis can live their best lives as we stop MS in its tracks,
restore what has been lost and end MS forever. Last year alone, through our
comprehensive nationwide network of services, the Society devoted more than $100
million to connect approximately one million people affected by MS to the
connections, information and resources they need. To move closer to a world
free of MS, the Society also invested $42 million to support more than 380 new
and ongoing research projects around the world. We are united in our collective
power to do something about MS now and end this disease forever. Learn more at http://www.nationalMSsociety.org. Early
and ongoing treatment with an FDA-approved therapy can make a difference for
people with multiple sclerosis. Learn about your options by talking to your
health care professional and contacting the Society via its website or
1-800-344-4867.
About the Advanced
Science Research Center at the Graduate Center, CUNY
The
Advanced Science Research Center (ASRC) is
the Graduate Centers
University-wide venture that elevates the City University of New Yorks legacy
of scientific research and education through initiatives in five distinctive,
but increasingly interconnected disciplines: Nanoscience, Photonics, Structural
Biology, Neuroscience and Environmental Sciences. The ASRC is designed to
promote a unique, interdisciplinary research culture with researchers from each
of the initiatives working side by side in the ASRCs core facilities, sharing
equipment that is among the most advanced available. More information is available
at http://asrc.cuny.edu.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central
nervous system that disrupts the flow of information within the brain, and
between the brain and body. Symptoms vary from person to person and range from
numbness and tingling, to walking difficulties, fatigue, dizziness, pain,
depression, blindness and paralysis. The progress, severity and specific
symptoms of MS in any one person cannot yet be predicted, but advances in
research and treatment are leading to better understanding and moving us closer
to a world free of MS. Most people with MS are diagnosed between the ages of 20
and 50, with at least two to three times more women than men being diagnosed
with the disease. MS affects more than 2.3 million worldwide.
###
